Top 50 Most Viewed Posts Last Week |
Today This Week Last Week This Month Last Month
|
1. MJS719: It looks like Leronlimab will compliment (929) (16) |
2. ohm20: It's absolutely an impediment to raising funds (711) (31) |
3. ohm20: Interesting mouse study in Glioblastoma. A cheap (658) (24) |
4. Katangolo: Love seeing us partnering. Little CYDY is growing (651) (12) |
5. Jake2212: Perhaps TAK, not MRK, lies in LL's future. We all (648) (32) |
6. My69z: "$5/$7/$10" buyout -- anyone even whisper (627) (16) |
7. grow: Every poster, paper, trial readout, and planned (622) (22) |
8. Evil Rabbit: That was Hulk / Blue Heel elsewhere. As a (613) (7) |
9. chazzledazzle: Reminded me that I’m curious about Chan. “ (546) (2) |
10. cardamine: Every party involved in quashing this miracle (530) (6) |
11. craigakess: Good post. There is much to be said for rational (529) |
12. KenChowder: Yes, and it's odd. Basically if you have CRC you (529) (12) |
13. FKAdamF.: Ohm20, once again, you are the voice of reason (527) (10) |
14. KenChowder: Pigs get slaughtered too. You can't milk a pig. (527) (15) |
15. KenChowder: Paper by Dr. Jay, Dr. Yang, Scott Hansen et al (519) (16) |
16. brentie: From MGK... (513) (5) |
17. mountaineer: Accepted 22 August 2024, Available online 30 (508) (2) |
18. My69z: chazzle, I'm morally speechless. What an (507) (5) |
19. My69z: Zika virus mAb's: Blocking the neonatal Fc (503) (1) |
20. sean007: Gilead sells Lenacapavir (aka Sunleca in the (502) (3) |
21. Enjay: BuildGoodThings posted this on reddit: Leronlimab (500) (16) |
22. craigakess: LOL. Nah, I like and respect EvilRbt as a person (497) (1) |
23. seemingly-harmless: new york times article on MASH today. trite (492) (1) |
24. sean007: The entire debate about COVID-19 and (492) (15) |
25. brentie: From stocktwits: A Randomized Placebo-Controlled (489) (12) |
26. docj: Interesting that CYDY doesn't spread the word to (484) (6) |
27. HHIGambler: 30 days from the week of Sept 9th would be Oct (482) (16) |
28. Evil Rabbit: Personally, I don’t care for the guy. And (478) (3) |
29. brentie: I know we saw the abstract, but I never saw the (471) (13) |
30. mfglola: Interesting connection between two of our (471) (4) |
31. Evil Rabbit: As soon as the relationship with the FDA was (467) (13) |
32. mountaineer: Someone will have to explain this. Doesn’t (467) (2) |
33. ohm20: I'm a little shocked at the massive number of (466) (9) |
34. docj: CytoDyn Engages Syneos Health as CRO For Its (465) (20) |
35. KenChowder: The word I liked best in the announcement today (463) (22) |
36. KenChowder: I suspect they heard back from the FDA and that (459) (7) |
37. Boatbuilder: I’m all for getting a good price, but remember, (456) (1) |
38. ohm20: That just means that shares that were previously (455) (9) |
39. Evil Rabbit: Perhaps now there’s a Covid paper published we (452) (6) |
40. biloxiblues: AI say's The TEMPEST trial's results indeed (450) (5) |
41. sean007: "These people"...noted as shorts... I question (449) (6) |
42. Figgs: I agree, things are progressing forward. Let (448) (12) |
43. chazzledazzle: Amazing. Thx. The 2 challenged subjects, got back (448) |
44. brentie: Article in the Columbian, nothing too exciting (445) (12) |
45. ohm20: Only 1.7 million shares traded. By now even you (445) (4) |
46. DJknows: Only thing that'll change these dynamics will be (444) (8) |
47. My69z: Clinicaltrials site search: Showing results for: (443) (4) |
48. KenChowder: I think MGK's AI presentation is worth listening (442) (13) |
49. Jake2212: " Syneos Health has helped to develop or (436) (23) |
50. dfwl28: Odds and Ends Your intestinal tract is your (436) (4) |